好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Outcome in Acute Basilar Artery Occlusion Based on Time and Severity at Presentation: A Retrospective Review
Cerebrovascular Disease and Interventional Neurology
P4 - Poster Session 4 (5:30 PM-6:30 PM)
3-032

To evaluate the impact of early presentation, NIHSS and GCS scores on the functional outcome of patients with acute basilar artery occlusion (aBAO).

aBAO is a subset of posterior circulation ischemic stroke causing brainstem and thalamic infarction. It is associated with high rate of mortality and disability.

This is a descriptive, retrospective single-center database correlating time and severity at presentation on functional outcome in aBAO patients. We reviewed patients presenting with aBAO or with symptomatic high grade stenosis in basilar artery at University of New Mexico Hospital (UNMH) between January 1, 2007 and June 31, 2017. Data was extracted from UNMH Cerner database and collected on secured Redcap™. Patients with missing data were excluded. All included patients were dichotomized into two groups based on 1-3 months post-stroke modified Rankin Scale (mRS). Patients with mRS 0-2 were grouped as good outcome and patients with mRS 3-6 as poor outcome.

Sixty six patients were identified with aBAO and 35 patients were included for final analysis. Eight patients (22.9%) had good outcome (mRS 0-2) and 27 (77.1%) had poor outcome (mRS 3-6). Of patients presenting within first eight hours, 50% and 59.2% had good outcome and bad outcomes, respectively. The NIHSS scores on presentation were as follows: with NIHSS 0, 37.5% in good outcome and 0% in poor outcome; NIHSS 1-4, 37.5% and 18.5%; NIHSS 5-15, 25% and 29.6%; NIHSS 15-20, 0%, respectively; NIHSS 21-42, 7.2% and 51.9% respectively. All patients in good outcome group presented with GCS 12-15 while in poor outcome group, 44.4% presented with GCS 12-15, 7.4% with GCS 8-12 and 48.2% with GCS 3-8.

In this descriptive analysis, patients presenting with aBAO within eight hours from symptoms onset did not correlate with favorable functional outcome (mRS<3). Meanwhile, low GCS and high NIHSS score were reflective of poor outcome. 
Authors/Disclosures
Sajid Suriya, MD
PRESENTER
Dr. Suriya has nothing to disclose.
Piotr Bzdyra, MD No disclosure on file
Mudassir Farooqui, MD Dr. Farooqui has nothing to disclose.
Asad Ikram, MD, MBBS Dr. Ikram has nothing to disclose.
Saif A. Bushnaq, MD (Texas Tech University Health Sciences Center) Dr. Bushnaq has nothing to disclose.
Saji Bushnaq, MD (The University of Tennessee) No disclosure on file
Christine Meadows, MD Dr. Meadows has nothing to disclose.
Michel T. Torbey, MD, MPH, FAAN (University of Oklahoma) Dr. Torbey has nothing to disclose.
Atif Zafar, MD (St. Michael's Hospital (University of Toronto)) Dr. Zafar has nothing to disclose.